In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Stryker's current price slightly exceeds the fair value by 1.8%, indicating near fair valuation with diverse method estimates ranging from $166 to $465. Financial health is generally strong, with liquidity and profitability at 4/5. Monte Carlo analysis shows high volatility and significant downside risk (58.3%), reflecting considerable valuation uncertainty.